Wellthytherapeutics
India, IN · Founded 2015 · 56 employees on LinkedIn · 2 known investors
Find your way into Wellthytherapeutics
Sign up to see every warm intro you have to Wellthytherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wellthytherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wellthy Therapeutics develops digital therapeutics and clinical decision support tools for pharmaceutical and life science partners to address treatment adherence, patient outcomes, and eligibility challenges in complex clinical conditions and rare diseases. The company builds software-as-a-medical-device (SaMD) solutions, companion therapeutics, and remote patient monitoring platforms with medical-grade compliance.
Founders & leadership
Wellthytherapeutics was founded in 2015 by Abhishek Shah and Prayat Shah.

Investors · 2
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Wellthytherapeutics do?
- Wellthy Therapeutics develops digital therapeutics and clinical decision support tools for pharmaceutical and life science partners to address treatment adherence, patient outcomes, and eligibility challenges in complex clinical conditions and rare diseases. The company builds software-as-a-medical-device (SaMD) solutions, companion therapeutics, and remote patient monitoring platforms with medical-grade compliance.
- Who founded Wellthytherapeutics?
- Wellthytherapeutics was founded by Abhishek Shah, Prayat Shah in 2015.
- Who are Wellthytherapeutics's investors?
- Wellthytherapeutics's investors include Merak Ventures, Saama Capital.
- Where is Wellthytherapeutics headquartered?
- Wellthytherapeutics is headquartered in India, IN.


